Agalsidase Beta

ATC A16AB04 · 11 markets · 20 records

Agalsidase Beta 11 markets · 20 records Forms

AU 3 records · 3 strengths

  • 35 mginjectionFABRAZYME agalsidase beta-rch 35mg powder for injection vial also in GB·ES·TW +1 unknown
  • 5.5 mginjectionFABRAZYME agalsidase beta-rch 35mg powder for injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 2 records · 1 strengths

GB 2 records · 2 strengths

CA 2 records · 2 strengths

SG 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名Fabrazyme ® 5mg (agalsidase beta) ×4

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    ES 2 records · 2 strengths

    TW 2 records · 2 strengths

    HK 2 records · 1 strengths

      2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名FABRAZYME FOR INJ 35MG ×4

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        FR 1 records · 1 strengths

        • 35 mginjectionFABRAZYME 35 mg, poudre pour solution à diluer pour perfusion also in AU·GB·ES +1

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.